A citation-based method for searching scientific literature

Erkut Borazanci, Ronald Korn, Winnie S Liang, Carol Guarnieri, Susan Haag, Courtney Snyder, Kristin Hendrickson, Lana Caldwell, Dan Von Hoff, Gayle Jameson. Oncologist 2020
Times Cited: 4







List of co-cited articles
16 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
633
75

Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
75

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Wungki Park, Jiapeng Chen, Joanne F Chou, Anna M Varghese, Kenneth H Yu, Winston Wong, Marinela Capanu, Vinod Balachandran, Caitlin A McIntyre, Imane El Dika,[...]. Clin Cancer Res 2020
47
75

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
75

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
75

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Siân Jones, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, Hirohiko Kamiyama, Antonio Jimeno,[...]. Science 2008
50

ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.
Lukas Perkhofer, Anna Schmitt, Maria Carolina Romero Carrasco, Michaela Ihle, Stephanie Hampp, Dietrich Alexander Ruess, Elisabeth Hessmann, Ronan Russell, André Lechel, Ninel Azoitei,[...]. Cancer Res 2017
56
50

Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action.
Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
300
50

Whole genomes redefine the mutational landscape of pancreatic cancer.
Nicola Waddell, Marina Pajic, Ann-Marie Patch, David K Chang, Karin S Kassahn, Peter Bailey, Amber L Johns, David Miller, Katia Nones, Kelly Quek,[...]. Nature 2015
50

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
50

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer.
Liya Ding, Hye-Jung Kim, Qiwei Wang, Michael Kearns, Tao Jiang, Carolynn E Ohlson, Ben B Li, Shaozhen Xie, Joyce F Liu, Elizabeth H Stover,[...]. Cell Rep 2018
173
50

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.
Eileen M O'Reilly, Jonathan W Lee, Mark Zalupski, Marinela Capanu, Jennifer Park, Talia Golan, Esther Tahover, Maeve A Lowery, Joanne F Chou, Vaibhav Sahai,[...]. J Clin Oncol 2020
100
50

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Matthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Zhi Rong Qian, Marisa W Welch, Lauren K Brais, Annacarolina Da Silva,[...]. Genet Med 2019
82
50

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Andrea Wang-Gillam, Chung-Pin Li, György Bodoky, Andrew Dean, Yan-Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, Jean F Blanc,[...]. Lancet 2016
511
50

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff,[...]. J Clin Oncol 1997
50

Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology.
Gregor Sturm, Francesca Finotello, Florent Petitprez, Jitao David Zhang, Jan Baumbach, Wolf H Fridman, Markus List, Tatsiana Aneichyk. Bioinformatics 2019
140
25

Differential expression analysis for sequence count data.
Simon Anders, Wolfgang Huber. Genome Biol 2010
25

E-cadherin is required for metastasis in multiple models of breast cancer.
Veena Padmanaban, Ilona Krol, Yasir Suhail, Barbara M Szczerba, Nicola Aceto, Joel S Bader, Andrew J Ewald. Nature 2019
222
25

Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling.
Yunliang Sun, Congshan Wu, Jianxia Ma, Yu Yang, Xiaohua Man, Hongyu Wu, Shude Li. Exp Cell Res 2016
39
25

Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
Mahnaz Janghorban, Li Xin, Jeffrey M Rosen, Xiang H-F Zhang. Front Immunol 2018
39
25

Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
Say Li Kong, Guoliang Li, Siang Lin Loh, Wing-Kin Sung, Edison T Liu. Mol Syst Biol 2011
141
25

Tumor metastasis: molecular insights and evolving paradigms.
Scott Valastyan, Robert A Weinberg. Cell 2011
25


Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.
Vindhya Palagani, Przemyslaw Bozko, Mona El Khatib, Hanane Belahmer, Nathalia Giese, Bence Sipos, Nisar P Malek, Ruben R Plentz. Carcinogenesis 2014
46
25

Metastatic progression is associated with dynamic changes in the local microenvironment.
Nicole M Aiello, David L Bajor, Robert J Norgard, Amine Sahmoud, Neha Bhagwat, Minh N Pham, Toby C Cornish, Christine A Iacobuzio-Donahue, Robert H Vonderheide, Ben Z Stanger. Nat Commun 2016
67
25

Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer.
Alvin P Makohon-Moore, Ming Zhang, Johannes G Reiter, Ivana Bozic, Benjamin Allen, Deepanjan Kundu, Krishnendu Chatterjee, Fay Wong, Yuchen Jiao, Zachary A Kohutek,[...]. Nat Genet 2017
189
25

Pancreatic cancer.
Audrey Vincent, Joseph Herman, Rich Schulick, Ralph H Hruban, Michael Goggins. Lancet 2011
25

Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.
Kyoung Eun Lee, Michelle Spata, Lauren J Bayne, Elizabeth L Buza, Amy C Durham, David Allman, Robert H Vonderheide, M Celeste Simon. Cancer Discov 2016
112
25

The evolving portrait of cancer metastasis.
P B Gupta, S Mani, J Yang, K Hartwell, R A Weinberg. Cold Spring Harb Symp Quant Biol 2005
63
25

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.
Andreas Wilm, Pauline Poh Kim Aw, Denis Bertrand, Grace Hui Ting Yeo, Swee Hoe Ong, Chang Hua Wong, Chiea Chuen Khor, Rosemary Petric, Martin Lloyd Hibberd, Niranjan Nagarajan. Nucleic Acids Res 2012
536
25

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
Angela M Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert,[...]. Nat Cell Biol 2017
431
25

The pathology and genetics of metastatic pancreatic cancer.
Shinichi Yachida, Christine A Iacobuzio-Donahue. Arch Pathol Lab Med 2009
125
25

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.
Prashanth Rawla, Tagore Sunkara, Vinaya Gaduputi. World J Oncol 2019
531
25

Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
Shinichi Yachida, Siân Jones, Ivana Bozic, Tibor Antal, Rebecca Leary, Baojin Fu, Mihoko Kamiyama, Ralph H Hruban, James R Eshleman, Martin A Nowak,[...]. Nature 2010
25

The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.
Hai Hu, Jun-Jie Hang, Ting Han, Meng Zhuo, Feng Jiao, Li-Wei Wang. Tumour Biol 2016
94
25

Fibroblast heterogeneity in the cancer wound.
Daniel Öhlund, Ela Elyada, David Tuveson. J Exp Med 2014
448
25


STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.
Ryan B Corcoran, Gianmarco Contino, Vikram Deshpande, Alexandros Tzatsos, Claudius Conrad, Cyril H Benes, David E Levy, Jeffrey Settleman, Jeffrey A Engelman, Nabeel Bardeesy. Cancer Res 2011
278
25

CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.
Eric Talevich, A Hunter Shain, Thomas Botton, Boris C Bastian. PLoS Comput Biol 2016
546
25

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.
Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, Tessa Fredriksen, Sarah E Church, Lucie Lafontaine, Nacilla Haicheur, Florence Marliot, Mihaela Angelova, Angela Vasaturo,[...]. Cancer Cell 2018
109
25

Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review.
Jonas R M Van Audenaerde, Geert Roeyen, Phillip K Darcy, Michael H Kershaw, M Peeters, Evelien L J Smits. Pharmacol Ther 2018
18
25

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, Karen Ng, Eugenia Flores Figueroa, Grainne M O'Kane, Ashton A Connor, Robert E Denroche, Robert C Grant, Jessica McLeod,[...]. Nat Genet 2020
117
25

Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.
Eldad Zacksenhaus, Mariusz Shrestha, Jeff C Liu, Ioulia Vorobieva, Philip E D Chung, YoungJun Ju, Uri Nir, Zhe Jiang. Trends Cancer 2017
45
25

xCell: digitally portraying the tissue cellular heterogeneity landscape.
Dvir Aran, Zicheng Hu, Atul J Butte. Genome Biol 2017
720
25

Absolute quantification of somatic DNA alterations in human cancer.
Scott L Carter, Kristian Cibulskis, Elena Helman, Aaron McKenna, Hui Shen, Travis Zack, Peter W Laird, Robert C Onofrio, Wendy Winckler, Barbara A Weir,[...]. Nat Biotechnol 2012
25

Fundamental role of C1q in autoimmunity and inflammation.
Myoungsun Son, Betty Diamond, Frances Santiago-Schwarz. Immunol Res 2015
34
25

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
25

Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.
Ishan Roy, Donna M McAllister, Egal Gorse, Kate Dixon, Clinton T Piper, Noah P Zimmerman, Anthony E Getschman, Susan Tsai, Dannielle D Engle, Douglas B Evans,[...]. Cancer Res 2015
34
25

The genetic evolution of metastatic uveal melanoma.
A Hunter Shain, Mette M Bagger, Richard Yu, Darwin Chang, Shanshan Liu, Swapna Vemula, Jingly F Weier, Karin Wadt, Steffen Heegaard, Boris C Bastian,[...]. Nat Genet 2019
72
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.